Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
Frontiers in Pharmacology · 09.11.2023 · 14
DOI: 10.3389/fphar.2023.1274248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.11.2023. Verfasst von Sheila I Peña-Corona und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, Mexico. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autosomal recessive congenital ichthyoses (ARCI) are a skin pathology due to genetic causes characterized by a variable degree of desquamation, accompanied by erythema. The degree of symptoms is variable, different altered genes are involved, and the symptoms drastically affect patients’ quality of life. Topical treatments are a first-choice strategy due to their ease of application and cost; however, enteral administration of retinoids offers greater efficacy, although with certain limitations. Despite the treatment alternatives, ARCI will persist throughout life, disabling people. Therefore, the search for new treatments always remains necessary. Especially repositioning drugs could be a short-term alternative to new affordable treatments for patients. Taking advantage of extensive knowledge of known drugs or biologics could ensure more accessible and possibly lower-cost treatments. This review briefly and concisely addresses possible repositioning strategies with drugs and biologics for ichthyosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
- Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de Mexico, Mexico.
- Facultad de Medicina, Universidad Veracruzana, Ciudad Mendoza, Veracruz, Mexico.
Zitieren
APA
Peña-Corona, S. I., Gutiérrez-Ruiz, S. C., Echeverria, M. L. D. C., Cortés, H., González-Del Carmen, M., & Leyva-Gómez, G. (2023). Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1274248
Vancouver
Peña-Corona SI, Gutiérrez-Ruiz SC, Echeverria MLDC, Cortés H, González-Del Carmen M, Leyva-Gómez G. Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1274248
BibTeX
@article{PeaCorona2023,
author = {Peña-Corona, Sheila I and Gutiérrez-Ruiz, Stephany Celeste and Echeverria, Ma de Los Dolores Campos and Cortés, Hernán and González-Del Carmen, Manuel and Leyva-Gómez, Gerardo},
title = {Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1274248}
}
EUVIMED